Aclidinium bromideProduct ingredient for Aclidinium

Name
Aclidinium bromide
Drug Entry
Aclidinium

Aclidinium is an anticholinergic for the long-term management of chronic obstructive pulmonary disease (COPD). It has a much higher propensity to bind to muscarinic receptors than nicotinic receptors. FDA approved on July 24, 2012.

Accession Number
DBSALT000003
Structure
Synonyms
aclidinium bromide, micronised
External IDs
LAS 34273 / LAS W-330 / LAS34273